Business Description
Nuvation Bio is a New York-based company focused on finding new treatments for cancer. Its first approved drug, IBTROZI, targets a specific genetic mutation found in certain lung cancer patients. The company is also running late-stage trials for a second drug aimed at treating a form of brain tumor driven by a particular genetic abnormality. Founded in 2018, Nuvation Bio continues to build its pipeline of precision cancer therapies.
